Strategies and Challenges in Clinical Trials Targeting Human Aging.
about
Of Cytometry, Stem Cells and Fountain of Youth.Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes.A Frailty Index Based On Deficit Accumulation Quantifies Mortality Risk in Humans and in Mice.Report: NIA Workshop on Measures of Physiologic Resiliencies in Human Aging.Advances in Therapeutic Approaches to Extend Healthspan: a perspective from the 2nd Scripps Symposium on the Biology of Aging.MortalityPredictors.org: a manually-curated database of published biomarkers of human all-cause mortality.Key proteins and pathways that regulate lifespan.Cellular Senescence: A Translational Perspective.The Clinical Potential of Senolytic Drugs.Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In VivoIdentification of HSP90 inhibitors as a novel class of senolytics.Rapamycin in mice.Translating Measures of Biological Aging to Test Effectiveness of Geroprotective Interventions: What Can We Learn from Research on Telomeres?Ayurveda and the science of aging.Metformin and ageing: improving ageing outcomes beyond glycaemic control.Methylomic survival predictors, frailty, and mortality.The application of information theory for the estimation of old-age multimorbidity.Healthy ageing: the natural consequences of good nutrition-a conference report.
P2860
Q36330702-D4009767-2BE0-4E26-9796-9FD2B7624087Q37322075-2A971CF4-8FB5-436F-9497-D1DCE0CEB2CCQ37654717-AE47EB0E-ACA1-4113-B308-04DDF999C1DEQ38370950-11CAA178-A50B-46C5-A003-1589F5DB68FEQ38430701-C45FA6B0-3A2D-4E60-B477-68A902AAB7E0Q38599879-41785CB1-A338-4EB8-9605-C126BDE98E42Q38926261-0F322811-4742-4DA9-875B-370EE98DEF91Q39246705-2AB012BD-70E1-49BF-AD76-A6CD10A69BC4Q39312260-55A70746-C627-4533-8806-95B6493774CBQ41285493-CF4E4FCD-2395-4E5B-91CB-90758E16C8AFQ41606906-3FDF29FF-3F57-41DE-BC04-8081F988AA84Q42262179-D2E07CDF-3439-4697-8BD1-DEC5C8C941BAQ47138998-A297906E-EFFE-4788-B1AC-BC644DF2DA73Q49588176-A1064818-5EDD-44CD-AB7C-404C69B1DD3BQ50431116-7C41A264-D076-440F-BF7A-323097EFB49AQ51765129-556D0DC6-A10E-4F58-8585-AE05A2EB310DQ54949820-C89D9DB4-6C66-40D1-B4F1-6DF81668B5B2Q55383174-44EB45E4-C337-41FF-A640-D2E7E18B4207
P2860
Strategies and Challenges in Clinical Trials Targeting Human Aging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Strategies and Challenges in Clinical Trials Targeting Human Aging.
@en
Strategies and Challenges in Clinical Trials Targeting Human Aging.
@nl
type
label
Strategies and Challenges in Clinical Trials Targeting Human Aging.
@en
Strategies and Challenges in Clinical Trials Targeting Human Aging.
@nl
prefLabel
Strategies and Challenges in Clinical Trials Targeting Human Aging.
@en
Strategies and Challenges in Clinical Trials Targeting Human Aging.
@nl
P2093
P2860
P356
P1476
Strategies and Challenges in Clinical Trials Targeting Human Aging.
@en
P2093
James L Kirkland
Jeffrey B Halter
John C Newman
Nir Barzilai
Shahrukh K Hashmi
Sofiya Milman
Steve N Austad
P2860
P304
P356
10.1093/GERONA/GLW149
P407
P577
2016-08-16T00:00:00Z